This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • An Open Label Randomised Trial of RNActive� Cancer...
Clinical trial

An Open Label Randomised Trial of RNActive� Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Cancer

Read time: 1 mins
Last updated:7th Apr 2014

The purpose of this study is to evaluate the induction of immune responses against CV9104 administered by conventional intradermal injection or with a needle-free intradermal injection device and to assess the safety and tolerability of CV9104 administered by conventional intradermal injection versus injection with a needle-free intradermal injection device versus no injection.

Category Value
Study start date 2014-04-07

View full details